Alnylam Pharmaceuticals
ALNY
#610
Rank
โ‚น2.794 T
Marketcap
โ‚น21,666
Share price
0.49%
Change (1 day)
39.08%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: โ‚น2.794 Trillion

As of January 2025 Alnylam Pharmaceuticals has a market cap of โ‚น2.794 Trillion. This makes Alnylam Pharmaceuticals the world's 610th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น2.794 T6.13%
2024โ‚น2.633 T31.68%
2023โ‚น1.999 T-17.35%
2022โ‚น2.419 T60.27%
2021โ‚น1.509 T36.7%
2020โ‚น1.104 T19.85%
2019โ‚น921.38 B78.63%
2018โ‚น515.80 B-35.88%
2017โ‚น804.49 B268.48%
2016โ‚น218.33 B-58.99%
2015โ‚น532.33 B12.16%
2014โ‚น474.61 B87.44%
2013โ‚น253.21 B382.76%
2012โ‚น52.45 B184.73%
2011โ‚น18.42 B-1.54%
2010โ‚น18.70 B-45.3%
2009โ‚น34.20 B-30.52%
2008โ‚น49.22 B5.79%
2007โ‚น46.53 B32.51%
2006โ‚น35.11 B202.91%
2005โ‚น11.59 B85.84%
2004โ‚น6.23 B

End of Day market cap according to different sources

On Jan 16th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:

โ‚น2.780 Trillion
by Yahoo Finance info icon info icon
โ‚น2.780 Trillion
by CompaniesMarketCap info icon info icon
โ‚น2.780 Trillion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น207.80 B-92.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.504 T 132.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น974.78 B-65.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น85.57 B-96.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.11 B-99.75%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น17.159 T 514.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น10.983 T 293.05%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น2.153 T-22.94%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel